Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5432 | 1558 | 28.3 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1070 | 9479 | UVEITIS//CYTOMEGALOVIRUS RETINITIS//OCULAR IMMUNOLOGY AND INFLAMMATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CYTOMEGALOVIRUS RETINITIS | Author keyword | 185 | 74% | 9% | 136 |
2 | CMV RETINITIS | Author keyword | 85 | 74% | 4% | 64 |
3 | IMMUNE RECOVERY UVEITIS | Author keyword | 27 | 83% | 1% | 15 |
4 | RETINITIS | Author keyword | 25 | 31% | 4% | 67 |
5 | FOSCARNET | Author keyword | 19 | 26% | 4% | 61 |
6 | GANCICLOVIR IMPLANT | Author keyword | 15 | 88% | 0% | 7 |
7 | INTRAVITREAL GANCICLOVIR | Author keyword | 15 | 88% | 0% | 7 |
8 | CYTOMEGALOVIRUS CMV RETINITIS | Author keyword | 11 | 78% | 0% | 7 |
9 | SHILEY EYE | Address | 9 | 14% | 4% | 58 |
10 | HIV RETINOPATHY | Author keyword | 8 | 75% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYTOMEGALOVIRUS RETINITIS | 185 | 74% | 9% | 136 | Search CYTOMEGALOVIRUS+RETINITIS | Search CYTOMEGALOVIRUS+RETINITIS |
2 | CMV RETINITIS | 85 | 74% | 4% | 64 | Search CMV+RETINITIS | Search CMV+RETINITIS |
3 | IMMUNE RECOVERY UVEITIS | 27 | 83% | 1% | 15 | Search IMMUNE+RECOVERY+UVEITIS | Search IMMUNE+RECOVERY+UVEITIS |
4 | RETINITIS | 25 | 31% | 4% | 67 | Search RETINITIS | Search RETINITIS |
5 | FOSCARNET | 19 | 26% | 4% | 61 | Search FOSCARNET | Search FOSCARNET |
6 | GANCICLOVIR IMPLANT | 15 | 88% | 0% | 7 | Search GANCICLOVIR+IMPLANT | Search GANCICLOVIR+IMPLANT |
7 | INTRAVITREAL GANCICLOVIR | 15 | 88% | 0% | 7 | Search INTRAVITREAL+GANCICLOVIR | Search INTRAVITREAL+GANCICLOVIR |
8 | CYTOMEGALOVIRUS CMV RETINITIS | 11 | 78% | 0% | 7 | Search CYTOMEGALOVIRUS+CMV+RETINITIS | Search CYTOMEGALOVIRUS+CMV+RETINITIS |
9 | HIV RETINOPATHY | 8 | 75% | 0% | 6 | Search HIV+RETINOPATHY | Search HIV+RETINOPATHY |
10 | MURINE AIDS MAIDS | 6 | 71% | 0% | 5 | Search MURINE+AIDS+MAIDS | Search MURINE+AIDS+MAIDS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VIRUS RETINITIS | 235 | 80% | 9% | 148 |
2 | DIHYDROXY PROPOXYMETHYL GUANINE | 91 | 94% | 2% | 32 |
3 | CYTOMEGALOVIRUS RETINITIS | 91 | 35% | 14% | 214 |
4 | CMV RETINITIS | 86 | 76% | 4% | 60 |
5 | INTRAVITREAL GANCICLOVIR | 83 | 74% | 4% | 62 |
6 | CYTOMEGALO VIRUS RETINITIS | 60 | 59% | 4% | 66 |
7 | IMMUNE RECOVERY UVEITIS | 29 | 65% | 2% | 28 |
8 | SUSTAINED RELEASE GANCICLOVIR | 29 | 58% | 2% | 34 |
9 | ANTICYTOMEGALOVIRUS THERAPY | 28 | 64% | 2% | 27 |
10 | RELEASE GANCICLOVIR IMPLANT | 27 | 70% | 1% | 23 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
HIV-associated retinopathy in the HAART era | 2005 | 51 | 149 | 70% |
Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome | 1997 | 94 | 67 | 75% |
Burden of HIV-Related Cytomegalovirus Retinitis in Resource-Limited Settings: A Systematic Review | 2013 | 8 | 29 | 52% |
Current status of HIV infection and ocular disease | 2012 | 7 | 49 | 61% |
Immune Recovery Uveitis: Pathogenesis, Clinical Symptoms, and Treatment | 2014 | 1 | 44 | 75% |
Posterior segment manifestations of HIV/AIDS | 2004 | 29 | 271 | 56% |
Cytomegalovirus infection in patients with HIV infection | 1999 | 39 | 86 | 60% |
FOSCARNET - A REAPPRAISAL OF ITS ANTIVIRAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN IMMUNOCOMPROMISED PATIENTS WITH VIRAL-INFECTIONS | 1994 | 122 | 120 | 46% |
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy - Recommendations of an international panel | 1998 | 93 | 93 | 44% |
FOSCARNET - A REVIEW OF ITS ANTIVIRAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN IMMUNOCOMPROMISED PATIENTS WITH CYTOMEGALOVIRUS RETINITIS | 1991 | 194 | 56 | 46% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SHILEY EYE | 9 | 14% | 3.7% | 58 |
2 | OCULAR INFLAMMATORY DIS | 8 | 27% | 1.6% | 25 |
3 | JACOBS RETINA | 6 | 21% | 1.7% | 26 |
4 | OPHTHALMOL NEUROL SURG | 2 | 67% | 0.1% | 2 |
5 | SHILEY EYE 0946 | 2 | 67% | 0.1% | 2 |
6 | DRUG DISTRIBUT | 2 | 50% | 0.2% | 3 |
7 | PACIFIC VIS FDN | 1 | 38% | 0.2% | 3 |
8 | FUNDUS PHOTOG READING UNIT | 1 | 100% | 0.1% | 2 |
9 | KLIN AUGENHEILKUNDE NETZHAUT GLASKORPERCHIRURG | 1 | 100% | 0.1% | 2 |
10 | OPHTHALMOL CLIN INVEST | 1 | 50% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000232688 | ACUTE RETINAL NECROSIS//PROGRESSIVE OUTER RETINAL NECROSIS//ACUTE RETINAL NECROSIS SYNDROME |
2 | 0.0000100805 | CYTOMEGALOVIRUS//VALGANCICLOVIR//GANCICLOVIR |
3 | 0.0000081882 | CYTOMEGALOVIRUS COLITIS//CYTOMEGALOVIRUS ENTERITIS//CMV COLITIS |
4 | 0.0000063208 | IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME//IMMUNE RESTORATION DISEASE//IMMUNE RECONSTITUTION SYNDROME |
5 | 0.0000060107 | ATOVAQUONE//TOXOPLASMIC ENCEPHALITIS//TOXOPLASMA ENCEPHALITIS |
6 | 0.0000058146 | DISPOSABLE PRISMS//TONOMETER TIPS//TONOSAFE |
7 | 0.0000057546 | EALES DISEASE//OCULAR TUBERCULOSIS//INTRAOCULAR TUBERCULOSIS |
8 | 0.0000049200 | CMV SPECIFIC T CELLS//ONCOHEMATOL GRP//CYTOMEGALOVIRUS SPECIFIC T CELLS |
9 | 0.0000047930 | ACYCLIC NUCLEOSIDE PHOSPHONATES//ACYCLIC NUCLEOSIDE PHOSPHONATE//PMEA |
10 | 0.0000046874 | VACUOLAR MYELOPATHY//AIDS DEMENTIA COMPLEX//CEREBRAL TOXOPLASMOSIS |